Proven Methods for Saving Time and Money Using In-Situ Activated Carbon Remediation
Learn More
- If you need assistance with a current project and would like to get a design and cost, please visit our Request a Design page.
- To get in contact with a REGENESIS Technical Solutions Manager use our Contact Us form.
It is what about estimating petroleum mass removal?
It’s a good question. Sorry, I didn’t touch on that. But, you know, petroleum and most contaminants, you know, the method of quantifying temporal contaminant mass per saturated soil volume will work. So, you know, go ahead and do it that way. So take a look at the…do that conversion where you take the aqueous samples and the soil samples, mathematically combine them into saturated soil and do the mass assessment with time based upon those. You know, there are also some CO2 and methane mass flux methods out there, but, you know, keeping it simple, mass for saturated soil, you know, works and works well.
Can the ISMs be used where the activated carbon is not delivered as a hydrocolloid?
Yeah. I think this one gets back to like if you don’t have that steric stabilization like the PlumeStop has on it within that. That makes the PlumeStop almost act like a soluble component, not like a colloidal compound, right, that settles out and has distribution issues. Yeah. I think that in native aquifer material, ISMs can also provide some value here, but they might not necessarily be…with these non-hydrocolloid activated carbons, they might not be delivered as efficiently. In order to, I guess it’s not stack the deck, but to make sure that you have a decent assessment of what’s going on in-situ, and you can’t count on the ISM being dosed the same way it would be if it were hydrocolloids that were being applied, you might need to pre-mix in the design dose of the activated carbon into the ISM matrix, that native matrix, you know, then deploy it. You know, then you can pull it with time and see, you know, “Am I getting degradation? Is the mass of sorbed material decreasing?” And it would at least give you a signal that it was time to go out and collect an actual saturated soil sample.
Has in-situ always been as efficient with mass removal as pump and treat?
Matt: That’s a great question. So, I think, there’s two components to this. So first of all, recently…over the past 10 years for sure but even more of like over the past 5 years, we’ve learned so much about degradation pathways and that they’re not as simple as kind of what I showed today’s example, that a lot of things go into them and that you need to pay attention to all those inputs to make sure you’ve designed well. So, I think, because those pathways have been…you know, detailed much more significantly recently, it allows design engineers to provide exactly the conditions that are needed to stimulate degradation. But I also think there’s a component…the second part of this is that remedial amendments have improved. Maureen, can you comment on, you know, how remedial amendments have changed over the past, you know, few years, you know, to accommodate this new science?
Maureen: Yeah. Matt. No, I’m happy to. You know, when thinking about, you know, ERD reagents, you can apply that, and you get some removal. But, I think, the advancements particularly with colloidal carbon gives you some more predictability. It also increases longevity. And so, I think, those components make it really important particularly if you’re thinking about a barrier and being able to maintain it over long term. And, I think, then the other aspect is rebound. You know, you may get low levels, or maybe you’re using ERD. It goes down and comes back up again, and you get this rebound, and being able to manage that rebound, that’s something else when you’re working with some of the colloidal carbons. I think that’s really advantageous and something that’s, you know, newer and gives us more tools and better tools for the in-situ.
You completed two pilot tests. Why did you go with PlumeStop over biogeochemical?
Good question. You know, the biogeochemical worked well and so did the PlumeStop, but we saw the biogeochemical as being additive to the PlumeStop. And we actually had a decent background of sulfate and iron, and the missing material what was a fermentable donor, which we were adding to stimulate the biodegradation as well. So, I think, we did get some biogeochemical conditions formed with our application. Good question. They both performed well, but we thought that we could get a biogeochemical component included with the PlumeStop as well.
How are bioremediation and iron-based abiotic pathways complementary?
Matt: I know Maureen’s all over this. We were talking about…
Maureen: Yeah. If you want, I’ll jump on this one. You know, Matt actually had touched on some of this, so, I think, a little earlier in his presentation talking about, you know, how you utilize both components. And, I think, they really are complementary, I think, in some aspects. Remember with the iron, that can help you really create those conditions immediately, those reducing conditions, and can have some very fast rates, particularly with the parent compounds. And then the bio just really supports this and may have some better efficiencies maybe even with some of the vinyl and, you know, other daughter products or even some other compounds where ZVI isn’t necessarily, you know, as effective as bio is. So, the two really work well together. And honestly, we’ve internally at Regenesis done a deep dive on some of our in-situ programs, you know, with and without iron, and we certainly have seen a statistically significant, you know, impact on the data that by adding the iron that we’re getting better overall results both in rate and, you know, percent reduction.
Matt: And, I think, that some of, you know, those synergies show up if you take a detailed look at each of the degradation path or each of those, you know, pathways. For example, you know, dehalococcoides, the main actor in sequential degradation of chlorinated solvents, you know, it requires B12. It can’t make B12 itself just like people can’t make B12. We’ve gotta take some vitamins if we wanna get B12 or have, you know, diets that are rich in B12. You know, dehalococcoides is kind of out there on their own because, you know, they don’t have access to these vitamins. But other microbes produce it, and then they’re able to grab access to it. And one of the groups of microbes that can make the B12 are iron reducers. So when you’re adding iron to a system and, you know, Geobacter growing up that makes B12, and it’s probably even the right lower ligand for only, you know, these 4 lower ligands of B12, and DHC uses one of them, so just having, you know, a diverse population of microbes making all sorts of different variants of the B12, you know, things like that, the details of those degradation pathways probably leads to a lot of those synergies that you’re seeing empirically.
Dane: Hello and welcome, everyone. My name is Dane Menke. I am the digital marketing manager here at Regenesis and Land Science. Before we get started, I have just a few administrative items to cover. Since we’re trying to keep this under an hour, today’s presentation will be conducted with the audience’s audio settings on mute. This will minimize unwanted background noise from the large number of participants joining us today. If the webinar or audio quality degrades, please disconnect and repeat the original login steps to rejoin the webcast. If you have a question, we encourage you to ask it using the question feature located on the webinar panel. We’ll collect your questions and do our best to answer them at the end of the presentation. If we don’t address your question within the time permitting, we’ll make an effort to follow up with you after the webinar.
We are recording this webinar, and a link to the recording will be emailed to you once it is available. In order to continue to sponsor events that are of value and worthy of your time, we will be sending out a brief survey following the webinar to get your feedback. Today’s presentation will focus on “Proven Methods for Saving Time and Money Using In-Situ Activated Carbon Remediation.” With that, I’d like to introduce our presenters for today.
We are pleased to have with us Matt Burns, technical director of environmental services at WSP. Matt has more than 25 years of professional chemistry and engineering experience. He is based in Boston and is responsible for the technical depth and breadth of the contaminated land site investigation and remediation service line. Matt also brings chemical and microbial process expertise to assist WSP teams with challenging investigation and remediation projects in the U.S. and across the globe. His area of expertise includes practical application of microbial and chemistry-based innovative remediation. We’re also pleased to have with us today Maureen Dooley, director of strategic projects at Regenesis. Maureen has more than 25 years of experience in the remediation industry. In her current role at Regenesis, she provides technical leadership for complex soil and groundwater remediation projects throughout North America as well as remediation design, strategy, and business development in the Northeastern United States and Eastern Canada. All right. That concludes our introduction. So now I will hand things over to Maureen to get us started.
Maureen: Well, thank you, Dane. And welcome, everyone. I understand how busy people are, so appreciate you choosing to participate in the webinar presentation today. The title of today’s presentation is “Proven Methods for Saving Time and Money Using In-Situ Activated Carbon.” We’re very pleased to have Matt Burns with us today to make this presentation. I’ve had the pleasure of working with Matt for many years, and when it comes to site remediation, I appreciate his ability where he has an academic level of understanding of complex aspects of remediation yet applies this knowledge in a practical way that results in effective application of technologies that achieves the goal of obtaining a reduced cost to closure. So, Matt, why don’t you introduce today’s talk and let everyone know what we’ll be covering?
Matt: Sure. Thank you, Maureen. And welcome, everyone. As Maureen and Dane mentioned, I’m with WSP. I’m fortunate to work with a great group of colleagues and some truly phenomenal clients. You know, they’ve supported our science-based approach that validates remedies in a fail small, succeed big manner. You know, together along with reputable and knowledgeable mediation professionals like Maureen and the others, our colleagues at Regenesis, we’ve been able to close out a lot of sites together. If you would like to contact either Maureen or me, you know, our email addresses are provided here, and they’ll also be provided in the last slide if you don’t have time to jot them down now. LinkedIn is also a great way to contact me.
So, hopefully, everyone is healthy physically and mentally, and being safe. And I guess there’s some good news starting to trickle in with vaccines and therapeutics, and hopefully, we turn the corner on this thing and get back to normal interactions soon. Until then, you know, please check in with more isolated friends and family and neighbors. Actually, I have one ask of all of you. It’s my first ask of any webinar is that, you know, pick one person in your life that might be a little bit more isolated because of COVID and give them a call tonight. All right. Let’s get to the webinar.
So, during this webinar, we’re gonna cover ideal characteristics of in-situ amendments. You know, we’re gonna take a look at life cycle costs of remediation using…in in-situ remediation using, you know, these amendments or…versus pump and treat. And we’ll go over a couple methods of how to do apples to apples mass removal comparisons between pump and treat and those in-situ alternatives. You know, even the presence of some confounding conditions such as use of activated carbon and bait elimination, stimulating amendments, these apple to apple mass removal comparisons can be made, and we’ll go over those. With that, I’ll pass the baton off to Maureen.
Maureen: Well, thanks, Matt. And honestly, related to the COVID, I just think that’s a great suggestion to reach out to people. So thanks for that. So, I wanna briefly describe the reagents that are used in the case studies that will be presented. And the focus here really is on the colloidal reagents. So first, we have PlumeStop. So PlumeStop is a colloidal activated carbon that’s a sorbent designed to remove contaminants from groundwater and promote degradation. The PlumeStop is composed of fine particles of activated carbon that are suspended using a unique polymer. The PlumeStop behaves like a colloid, binds to the aquifer matrix and rapidly sorbs contaminants and expedites contaminant degradation. I mean, a real key feature of the carbon is the vast surface area. It’s something like, you know, 100 acres for 1 pound of the activated carbon or colloidal activated carbon. And what that translates to is rapid sorption and also provides a vast surface area for microbial colonization. And another important factor is that we can inject the colloidal activated carbon under low pressure and get widespread distribution.
Another reagent that can be used to enhance remediation efficiencies is sulfidated zero-valent iron. The SMZVI is also a colloidal reagent at 1 to 4 micron in size. So why is sulfidation important? Well, when you have bare ZVI in an aqueous solution, it’s going to react with water, and that’s what’s favored. So, while generating hydrogen, that can support biological degradation, but it’s also a wasted reaction. So if we amend the iron by depositing a layer of iron sulfide, you can increase the efficiency of the zero-valent iron. In some of our internal studies, we’ve been able to see a 30 times increase in degradation rates when using sulfidated ZVI. You know, the other important feature is we’re going to reduce daughter product formation with chlorinated solvents. Now, is it gonna be gone completely? You know, probably not, but certainly, you’re gonna increase your conversion and your rate of conversion to ethene and ethane.
You know, the other characteristic of the SMZVI is that it’s colloidal, and it’s a small particle, and as I said, can be injected easily. So you see in this picture you have the SMZVI on the left. And so that’s a suspension. And so, again, as I say, you can inject this easily. But the larger particles are going to tend to settle as you see with a 40 microns ZVI in water. And to be able to inject it, you may need a thickener like a guar, and you’re gonna have to use high pressure or fracturing. So with both of these colloidal reagents…and in this figure, what we’re going to see is an illustration of the colloidal reagents being injected into the subsurface. And as mentioned, it’s injected under low pressure. And our ability to distribute the reagents across the target zones is critical to the success of any project. This is a key advancement. So think of these original, like permeable reactive barriers where you needed to create trenches and physically mix an iron to create this iron wall. Now we’re able to cost-effectively apply and inject using methods like direct push where ultimately, we’re gonna paint the subsurface of these targeted zones with iron and carbon to be able to create, you know, something like a PRB.
So in this slide, we’re looking at…we refer to our mode of action. So, initially, you have…the colloidal carbon becomes attached to the soil, and so as the contamination moves through, it’s going to soar. And so we also typically co-apply an electron donor or electron acceptors to promote biodegradation, and we may also include an ISCR reagent like SMZVI. And so these reagents are set up to create conditions to enhance degradation. But in addition, you’re going to be able to manage back diffusion. So while we have this sorption and degradation that continues, and the sorption sites are freed up in the barrier, and it’s maintained over the long term, but we’re also able to manage that contamination that may be migrating from finer grain materials into the more productive areas or more conductive zones. So, in essence, we’re not going to see rebound because we’re able to manage the back diffusion. So, this allows us to achieve and maintain low cleanup standards, which also can mean, you know, meeting part per trillion levels with PFOS. There may be no degradation with a PFOS compound, but we’re still able to meet sometimes these very low cleanup standards.
So, some of the key features of utilizing these colloidal materials is, one, they last a long time. It could be years to decades is the sort of treatment time we can be looking at. We can work with a wide range of contaminants, VOCs, petroleum hydrocarbons, chlorinated benzenes, PFAS. And our results can be very fast. And something else I want to emphasize is ability to be predictable. We can use models, and we’re using isotherms and degradation rates and allows a level of predictability. These are environmentally friendly. If you’re looking at sustainable sort of applications, this certainly fits the bill. Flexible, we can combine with different technologies, and then ultimately, it gives us an ability to reduce liability and save money. So with that, we’ll turn it back over to you Matt.
Matt: Thanks, Maureen. Well, last year, WSP and Regenesis collaborated on this eBook, “Real World Business Cases: Where In-Situ Remediation Saved Time & Money versus Pump & Treat.” You know, there are three case studies presented in there. In each case study, there was a brief site background and technical discussion, but the primary focus was on life cycle cost comparisons between in-situ technologies and pump and treat. Two of the featured sites included in-situ remedies with PlumeStop-based treatment. The other was in-situ chemical oxidation. You can download the eBook from the Regenesis website. You’ll find eBooks under the Resource tab. While you’re there, I also recommend that you explore the content. There’s a lot of good information in that tab.
So case study two is one of the, you know, featured in the PlumeStop application sites inside the eBook. I’m singling it out because I’ve presented on this site as part of two other Regenesis webinars, and it would be a chance for some continuity for those who attended the previous webinars. You know, there’s a lot of technical content in those previous webinars that take really deep dives into advanced diagnostics and the science behind site characterization and the selected remedies. You know, I’m not gonna talk about that stuff today. I’m not taking that same deep dive. Today, I will focus in on addressing, you know, the value of in-situ remediation as compared to pump and treat.
Here’s a refresher on the Arkansas site background. From the information written on the logbook, you’ll see that we performed two pilot tests at this site before going full scale. In 2016, we applied amendments to stimulate biogeochemical reduction through biogenic formation of iron sulfides, you know, from native and introduced iron and introduced sulfate. The amendment formulation also included nutrients in a bioaugment to stimulate biodegradation along the hydrogenolysis pathway and sequential reduction pathway. I’ve found that bioremediation is very compatible and synergistic with abiotic reduction. A more in-depth discussion of that treatment is in the May 2018 webinar that you can access through the Resources tab on the Regenesis website. And in 2017, a PlumeStop-based pilot test was performed. More information on that pilot and the technical deep dive was presented in the May 2019 Regenesis webinar.
So anyhow, the site is a former manufacturing facility that began operating in the early ’60s. Operations included the use of chlorinated solvents. Contaminants include TCE and its daughter products over a wide area. The affected groundwater is present in fractured sandstone. You know, a teleview image of the matrix is shown on the right side of the logbook. This sandstone has a relatively high primary porosity as well as a significant fracture network. The fracture network is predominantly horizontal fracture pattern with some high angle fractions that are also present…fractures that are also present. Because of the site characteristics, we expect long-term back diffusion from this matrix. The long-term back diffusion potential was the primary driver for pilot testing biogeochemical and PlumeStop-based amendments. You know, both of these technologies have extended in-situ longevity.
Here’s a plan view of the site. You know, there’s not really much to focus on this slide yet other than to show that, you know, the biogeochemical and the PlumeStop pilot tests were performed in adjacent areas. And maybe this might jog your memory a bit about these previous webinars. I forget the names of sites and locations a lot, but I never forget a Plume map, and, I think, a lot of people are like that. All right. This is the cross-section that’s probably more relevant. It shows the site conceptual model with the former facility at the top of the hill. The pilot test area is a few hundred feet downgradient of the facility. The Plume discharges some VOCs to a gaining stream located about a thousand plus feet away from the facility. The beta zone sources have been excavated and removed, and a vapor mitigation system has been installed in the buildings that overlay the plume.
So, let’s get back to the eBook and the life cycle cost comparisons between pump and in-situ treatment. You can see in the left-hand column the cost comparison table. We included pilot test costs in this comparisons table. Those were $75,000 for the pump testing that we did there and $125,000 for the in-situ pilot testing. Other design components that were included were design and installation, O&M, and monitoring. For the pump and treat scenario, costs included a half million for design and installation. You know, $300,000 for O&M and about $35K a year for monitoring. You know, the one year total is about $900,000 for year 1. That’s capital costs largely taking up the most of that money. The cost for O&M and monitoring were extended out over a 10-year period of time. This results in a total net present value cost of about $3.4 million, and we discounted this at a rate of 3%.
For the in-situ scenario, the costs include $125,000 for the pilot, $1 million for the design and installation of the PlumeStop in-situ remedy and, you know, that same $35,000 again for annual monitoring. We have a conservative with the in-situ remediation post-year one design and O&M costs. We carried the need to reapply a fermentable substrate to keep bioremediation active in the microbes degrading the chlorinated ethenes happy. This carried through every other year and $100,000 per application, you know, with $30,000 on top of that every year for, you know, refining designs and making sure that we get that application correct every time we do it. It’s also important to consider that the maintenance of the microbial community is very important in a PlumeStop remedy. Anyhow, the total net present value costs for the in-situ PlumeStop remedy is just over $2 million, you know, a savings of about $1.4 million compared to the pump and treat option over that 10-year lifespan.
The graph of the cost, you know, shows the data in a more succinct manner. You know, despite the cost being about $200,000 greater, those capital costs being $200,000 greater for in-situ than pump and treat, the initial higher costs had a very quick return on investment. The high O&M costs associated with the pump and treat really make in-situ a much better financial option. So, Maureen, I think, you’re gonna pick it up and summarize a little bit of these benefits of these pump and treat systems…I mean, sorry, the in-situ systems.
Maureen: Yeah. I know. I always like to go back to this slide, which is really our four pillars of, you know, in-situ remediation and some of the different, you know, components we want to incorporate, you know, reactivity, ease of use, distribution, and persistence but, you know, really focusing here on reactivity. You know, now that the data are coming in, and this project has been installed, you know, how do you really now take a look and do this comparison? And one of the things, when Matt and I were reviewing some of this data, is, you know, a question we asked ourselves, you look at degradation, you look at, you know, reductions, but really what’s the total mass reduction? We move ahead, you know, we install these colloidal reagents, we do all the things, but at the end of the day, what’s their performance and what sort of total mass reduction has been observed? Matt’s gonna get into some details on that and some interesting information.
Matt: Yeah. Maureen, I agree. A side-by-side mass removal comparison between in-situ remedies and pump and treat would be important. You know, after all, what good is lower cost if effectiveness isn’t comparable? You know, with most technologies, a mass removal assessment, you know, is even aligned with remediation goals, right, decreases in the concentration of regulated chemicals with treatment. Basically, what’s the difference in the groundwater contaminant concentrations in samples collected at baseline and those collected after treatment? But with activated carbon-based remedies, where by design VOCs are removed from the dissolve phase nearly immediately, discerning between sorption and destruction is really critical for making the mass removal assessment. And frankly, I think, it’s the biggest question I get from regulators when including activated carbon in amendment formulation.
So here’s a more visual explanation of the sorption mechanism. We’ll take a deep dive on how to figure out these mass removal rates. Sorry. So here’s a bit of an explanation of how the activated carbon works. So here’s a glass of water that’s gonna be our aquifer. Let’s install a well, and we should have added the sand first but… Now that’s better. Add the contaminant. And conveniently, our contaminant is color red. Treat with PlumeStop. Add the PlumeStop and biostimulants. You can wait a while for the PlumeStop to settle out of solution as Maureen mentioned above when it will associate itself with the soil phase. This could take a month or two. That depends upon the groundwater chemistry of the site, or a cationic parking agent can be added to cancel out, you know, the negative charge of the PlumeStop. And, you know, it would speed things up significantly, and it’s particularly useful for applications where limiting PlumeStop migration is desired like near a water body. So you can control the distribution of PlumeStop. It won’t run forever. You can make it fall out of solution very quickly or wait a month or two if you want that increase in distribution from natural flow.
Whether with time or with a cation application, I end up with an aqueous phase free or nearly free of contaminants, you know, by design. You know, this is because the contaminant partitioned to the soil phase the PlumeStop, which fell out of solution and becomes part of the saturated soil’s matrix. Hopefully, it’s degrading too. You know, why is this important? Why is degradation important, you know, on that activated carbon?
Well, following the treatment with activated carbon, the groundwater concentration, the aqueous phase concentration is like an order of magnitude lower than in pre-treatment concentrations. You know, it often complies with regulatory standards, but that’s not a good comparative endpoint. Sorption does not destroy contaminant mass. Simply looking at changes in groundwater VOC concentrations just isn’t appropriate. It can even be detrimental to do so. That’s because activated carbon has a limited sorptive capacity. You know, room needs to be made by destructive treatment to accommodate additional contaminant loading. The additional loading can come from, you know, for example, migration of upgrading contaminated groundwater into the treatment zone like in a hydraulic barrier configuration or in a barrier configuration or by back diffusion as Maureen mentioned in her illustration. It can even come from naturally occurring organic materials. You know, without contaminate destruction, additional contaminant or naturally occurring organics may eventually exceed the sorptive capacity of the activated carbon and potentially bump off contaminant.
You know, here is an older but applicable guidance on granular activated carbon. On the second page, it notes that their high levels of background organic matter may result in rapid exhaustion of carbon. You know, it’s pretty easy to imagine a scenario where background levels of organic matter, even lower than that 10 milligram per liter amount noted in the guidance document here. You know, when continuously loaded, you know, this amount of organic matter background could cause an issue potentially leading to desorption of target contaminants into the future. So it’s important to have a destructive mechanism included to make sure the remediation is complete and that there are no surprises in a couple of years down the road. And, of course, complete degradation is the ultimate endpoint to assess the effectiveness of any destructive remediation technology.
In the May 2018 Regenesis webinar, we took a really deep dive into diagnostics to demonstrate degradation of sorbed contaminants. You know, the webinar compared degradation pathways to taking a trip to an unfamiliar area before GPS. Back then, after every turn, I would look for visual clues, landscape features and signs that indicate that I’m on the right road. You know, observing these clues, the diagnostics used along the trip to my destination, right? If I looked at these signs and key points, you know, then the consequences of making a wrong turn would never be that significant. But if I didn’t look for these signs and the landscape features very frequently and missed something, then I could end up way off course and maybe not even reach my destination.
The degradation pathway or pathways in the case of combined remedies is the remediation roadmap. The specific reactants, products, intermediates, nutrients, catalysts, etc., and all these end up in this equation. They all vary, of course, by the contaminant being treated and the pathways that you’re trying to stimulate. Key reactants and products, anything needed to facilitate the reaction are great candidates to include in performance monitoring plans. But the performance monitoring plans don’t need to mirror like, you know, deep dives that you do for M&A type investigations. You know, for M&A investigations, the degradation pathway is unknown and needs to be identified. The stoichiometry of the equation needs to be known. The presence of enough reactants, the proper conditions to drive and complete the degradation all needs to be figured out.
At bioremediation sites, you know, the design engineer selects the pathway to stimulate and provides the proper conditions. You know, careful consideration is given to the amount of reactants, the macronutrients, electron acceptors, donors, everything that’s needed to drive the reaction. So performance monitoring is really…with engineered system is destination verification, you know, at the working level. You know, are there any issues that need to be fixed level of, you know, engineering and performance monitoring? So observing expected trends is evidence of activity along the targeted degradation pathway and realizing design goals.
You know, the webinar in 2018 and ’19 went to detail on assessing the entire degradation pathways, you know, looking at direct evidence and mechanistic data and even empirical relationship data. You know, for assessing mass removal though, if that’s what we’re focusing on, you can just look at the direct evidence of degradation, you know, contaminate concentrations decrease, and end-product accumulation. Isotopic data can also be used to estimate mass removal, but I don’t typically use isotopic data that way. I use it more qualitatively. It answers a simple question, is it degrading or not? I don’t typically try to correlate, you know, appropriate enrichment studies to field conditions and tease out mass removal. But that can be done. As I’ll be showing in the examples today, there are a couple of ways to get around some sorbed mass issues using really simple methods and not having to rely upon some of the more advanced diagnostics. But first, Maureen’s gonna tee up the discussion with a case study.
Maureen: Oh, thanks, Matt. So, you know, this question, do we have biodegradation? We’re dealing with a colloidal carbon that’s sorbed, and, you know, we consistently get this, “How do I know things are degrading?” So, I just wanna give an example here and also just refer back, we have a lot of proof of concept, lab studies that have been conducted looking at this question. And you can go to our tech bulletins on our website. But I wanted to get into this direct evidence. So, here’s an example of a barrier that was installed where we have PlumeStop, SMZVI. We also have HRC to promote reductive dechlorination along with some microbes. We have a well within the barrier area, and then there’s wells that are downgradient of the barrier. Next slide, please. So in the results, what we see is a very rapid reduction of the PCE and TCE. Now, that’s something we certainly would expect with the colloidal activated carbon. But we very immediately saw an increase in formation of ethene and ethane. So this is really the ultimate, you know, direct evidence that you would be able to obtain and show that you’re getting degradation. And interestingly enough, we had really no CIS or vinyl chloride that was generated. And again, this is the well that’s within the barrier itself. So next slide, please.
So in the downgradient wells, what we see is…you know, over time, we’re starting to see the reductions of the target compounds. The red line refers to TCE, but the dotted line that you see there is the concentration of TCE that we predicted over time since we incorporate internal models that allow us to design and determine how much material we need to be able to achieve a certain, you know, barrier longevity. So we see the TCE degradation is actually doing better than the predictive model, and then the yellow and sort of orange-yellow color represent the cis-DCE and vinyl chloride that’s present downgradient, and you’re seeing that reduction. And compared to our predictions, the cis-DCE is actually doing a little bit better and then the vinyl chloride. But this is really just to, again, illustrate that you can install the barrier. You can get ethene, ethane formation, which gives you direct evidence of degradation. But also we do have a level of predictability here. So we can look and see, “Is everything performing as expected?” So with that, Matt, we’ll turn it back to you.
Matt: Thanks, Maureen. So, now that we know…Maureen just showed a great example of showing that degradation is happening. And, you know, you can’t argue that degradation is not going on in the presence of ethane and ethene in that system, but it doesn’t do a complete mass balance, so that you can know how much has been destroyed. So that’s what we’re gonna focus on for the balance of this talk. So, let’s get back to this Arkansas site. So, we went beyond the pilot test, and we performed a full-scale PlumeStop plus bioremediation treatment in April of 2019. You know, unlike the case study that Maureen just presented, ZVI was not included in the formulation. We injected through 26 PVC wells, you know, shown in purple on the map to the right. In total, nearly 200,000 gallons of amendment and mixed water were injected at average flow rate of about 12 GPM per well. We got through the injections relatively quickly by using a manifold to simultaneously inject up to four wells at a time. There were really no surprises during application. The application was really consistent with the design parameters identified during the pilot testing. And we also had some great crews out there performing the work. So the goal of the remediation was to limit the transport of the VOCs and promote biodegradation. You know, here’s a very simple degradation pathway for TCE, you know, the contaminant concern of the Arkansas site. It’s our roadmap, and I’m sure you’ve all seen this before. There is no mention of, you know, dehalococcoides, pH constraints, cobalamin, lower ligand requirements, etc., etc., in this simplified roadmap. Those, you know, milestones are included in those other webinars. But it is detailed enough to depict what happens to aqueous phase concentrations of TCE and its hydrogenolysis degradation products, you know, when you end up treating these with activated based carbon amendments.
You know, TCE has a great activated carbon isotherm. It sorbs to the activated carbon, which is associated with the solid phase as, you know, Maureen has discussed and is removed from the groundwater. So, groundwater samples won’t have any or not much TCE in it. Now, DCE has an okay isotherm. Some of it will sorb and some will remain in groundwater. Vinyl chloride has a poor isotherm. You know, typically not much of it is sorbed and most of it is in the groundwater. Ethene doesn’t, you know, partition appreciably to the activated carbon. Just about all of it remains in the groundwater. Because ethene is the desired end product, you know, it doesn’t sorb to the…and because it doesn’t sorb the activated carbon and it’s, you know, fairly conservative, it can be used as a good indicator of mass destruction. And by being conservative, what I mean there is that it doesn’t really degrade in anaerobic conditions that are established as part of the conditions needed to stimulate the sequential reduction. So, ethene concentrations increase in groundwater samples with time and treatment, and that increase can be used to quantitatively estimate mass removal along hydrogenolysis pathway. But ethane will degrade anaerobically. And, you know, since there’s always some oxygen leaking its way into an open system like our remediation site, you know, leaks in from like air-water partitioning and stormwater infiltration, you know, in ethene-based mass removal estimate, if anything it’s probably biased a little bit low. There’s probably more generated than you’re actually quantifying because aerobic processes, even though they’re not very, very active, there’s still a little bit getting in there, will lower the concentration of ethenes compared to what you’re measuring. But there’s no harm in being a little bit conservative.
So here are the results, the Batesville site. You know, the average ethene concentration from all site wells measured in the year 1 post-treatment groundwater samples was about 190 micrograms per liter or 6.8 micromoles. Extrapolated across the entire groundwater volume, you know, the entire plume, after 1 year, that’s about 1,700 moles of ethene were produced. This is equivalent to about 500 pounds of TCE that was destroyed by the treatment. This is pretty good when considering the sequential nature of the degradation pathway. It takes time to progress to the phase when ethene is the most abundant daughter product being produced along the degradation pathway. For the pump and treat comparison, hydraulic barrier, got some serious consideration for implementation at the Arkansas site. We collected the data needed to design it including a substantial pump testing activities where we were able to gather key design criteria and quantify those for design purposes. You know, in some of those criteria, you know, we identified a sustainable yield about 2 GPM across the site, and we identified a 130-foot wide drawdown perpendicular to the groundwater flow. Drawdown was at least two feet. So, two feet drawdown across 130-foot wide cross-sectional area. It’s pretty substantial. So, based on this data, you know, a network of 10 extraction wells with a cumulative extraction rate of about 20 GPM was contemplated.
To calculate the expected mass removal rate over the first year of treatment, you know, the same period of comparison as the PlumeStop bioremediation scenario we just discussed, you know, baseline pre-treatment groundwater chlorinated VOC concentration data were used. The average chlorinated VOC concentration was about 5,500 micrograms per liter or 47 micromoles. Over one year of treatment at 20 GPM, you’re using an uptime estimate of about 75%, 1,400 moles of CVOCs or the equivalent of 410 pounds of TCE would have been removed by that, you know, hypothetical pump and treat system.
So here’s the year one mass removal comparison. Equivalent of about 500 pounds of TCE removed for the in-situ remediation versus 410 pounds for the pump and treat, you know, basically the same or close enough, so equivalent mass removals between the technologies. But, you know, before I ran these calculations, I thought for sure that pump and treat would outperform in-situ during the first year. This is because the sequential nature of the degradation, the time microbes take to reduce TCE to DCE and DCE to vinyl chloride, you know, before getting to the serious ethene production phase of the sequence. Okay. In summary, you know, at this site, mass removal performances were similar, but the costs were not. The in-situ option saves about, you know, $1.5 million over 10 years as compared to the pump and treat alternative. You know, our decision to implement an in-situ remedy at the Arkansas site over a pump and treat remedy is looking pretty good at this point and that we’re gonna be able to realize those savings with at least a comparable performance between the in-situ treatment and the pump and treat. So the value is there for the in-situ remedy.
So on to another site. I like to add iron and Maureen does too as she showed in her presentation. I like to add it as either ZVI or as biogenic ferrous sulfide like the pilot test we completed initially at the Arkansas site. Both of these stimulate the elimination pathway where the ZVI or iron sulfides they both stimulate that elimination pathway or beta-elimination is what you probably commonly hear. Lots of technical reasons that I have spoken out at length during some of these previous webinars for combining bio. They’re very complementary pathways. And I’ve found that with these pathways, one plus one equals more than two. But quantifying mass removal becomes a bit more difficult with these amendments.
You know, with PCE being sorbed to the activated carbon, you know, that’s a confounding factor, but also this poor product recovery is associated with using these elimination stimulating pathways. But there is a relatively easy way to calculate mass removal with activated carbon plus biostimulation plus beta-elimination pathway stimulation. You know, perform a saturated soil balance, mass balance with time. That’s a great way of, you know, figuring it out. So figuring out direct comparisons of how much contaminant has been destroyed. You know, don’t just look at the aqueous phase. Look at the saturated soil phase. You know, the CVOCs in groundwater plus the CVOCs in soil, what happens with those with time? To do this, in addition to collecting groundwater samples, saturated soil samples will also need to be collected. The soil data will need to be adjusted by, you know, subtracting out the amount of VOCs attributable to the aqueous phase, you know, the aqueous VOCs that are in the groundwater. Determining the CVOC contribution to soil moisture is, you know, done simply by multiplying the percent moisture of the saturated soil by the, you know, groundwater results from an adjacent well and then just pull it out of there. After the adjustment for soil…an adjustment for soil bulk density needs to be made too. You know, I like to keep it simple and multiply it by the dry bulk density of a cubic meter of soil about 1,600 kilograms. You know, with the soil VOC content defined, all that’s left is, you know, back in groundwater. So what’s the concentration…how much groundwater VOC contribution needs to be put into the unit volume of aquifer material? And in my examples, I like to use the cubic meter again.
You know, the groundwater contribution of the CVOCs is simply multiplying the CVOC concentrations by the soil porosity, you know whatever volume that you use. Again, I like one cubic meter. So, for example, for porosity of 30%, multiply the concentration that you get from the groundwater data times 300 liters. With the VOC concentration normalized and the mass of CVOCs per unit of saturated soils, we’ve mathematically just adjusted everything. So we’re not just looking at the soil concentration, and we’re not just looking at the aqueous concentration, we’re looking at the concentration of CVOCs per unit of saturated soils. You know, because you’re looking at it as a per unit of saturated soils, a direct comparison of the disappearance of CVOCs with time can be made.
I know Geoprobe’s in this photo. I know it’s rigged up for injections and not for soil sample collection, but it’s a great photo. In any way, I don’t use Geoprobes or any other type of drill rig to collect those saturated soil samples, you know, that are necessary for this sort of analysis. What I do is I use aquifer material in-situ microcosms. The matrix for the in-situ microcosms are collected during an earlier investigation phase or even during, you know, injection well installation. The samples are dried out to remove VOCs, and for bedrock, the rock is smashed up and sieved. You know, dried samples are then loaded into screen housings, and several ISM units, those screen housings are suspended within each monitoring well for at least a couple weeks before a treatment is performed. This is done so that the CVOC groundwater soil equilibrium has time to re-establish. And with soluble amendments, you know, and hydrocolloids like PlumeStop and S-MicroZVI, the ISM is treated in-situ with the rest of the aquifer in the same exact manner. The ISM soil samples can then be retrieved, you know, with groundwater from that same well to perform the saturated soil matrix mass balance. There are some other data like, you know, the ability to quantify PlumeStop delivery efficiency that can also be teased out of these aquifer material ISM data. But I went over that one in the other webinar as well. So if you’re interested in that, please check it out.
So, after one of my REGENESIS webinars, a new client asked to take a look at one of their underperforming sites. The site had a very expensive and inefficient property line hydraulic barrier pump and treat system. Well, we looked at it, and the pump and treat system had, you know, some big issues. So we performed pre-design studies in that fail small, succeed big, science-based manner that I mentioned at the beginning of the webinar. And these studies included hydrophysical investigation that identified some flow zones or the high mass flow zones and in-situ microcosm study that’s different than what I’ve been just talking about. It’s the microbial insights in-situ microcosm studies which you amend a small sample, those in-situ microcosms, and take a look at all those advanced diagnostics to nail down an amendment formulation. So, we were able to demonstrate on the small scale the viability of the in-situ remedy before we, you know, scaled it up to full scale or even pilot scale. So it’s another one of those a great fail smalls to see big methodologies. Anyhow, in July 2019, we decommissioned the pump and treat system and performed the in-situ treatment. The amendment formulation included PlumeStop, biostimulants, and S-MicroZVI. We also, you know, pre-placed those aquifer matrix ISMs when the performance monitoring wells.
Here are the Plume’s wide average results for three months and nine months, you know, post-treatment. Three months after treatment, the equivalent of 285 pounds of TCE was present in the treatment zone. Nine months after treatment, there was 180 pounds left. You know, the equivalent of 105 pounds of TCE had been destroyed over those 6 months. You know, these early results are phenomenal. The historic performance of decommissioned pump and treat system isn’t even close to what was achieved by the in-situ treatment. Although the cost comparisons for this case study wasn’t included in that eBook, this project is more recent than that, the annual costs for the in-situ treatment will be far, far less than the underperforming pump and treat system. And the mass removal isn’t even comparable with the uptime that that pump and treat system had. So, this site also shows the cost and performance, you know, the value of the in-situ alternative over the pump and treat alternative. So, with that, I think, we can hit a couple of conclusions. And, Maureen, you wanna kick us off?
Maureen: Sure. I think, again, just, you know, reiterating some of the comments I had made before that when working with, you know, PlumeStop and some of the associated reagents, you know, we can create, you know, a barrier or treatment system that lasts a long time, can be fast. Now we know the types of mass removals we can achieve. And, you know, ultimately, we’re looking at an effective technology at much lower costs.
Matt: Yeah. The in-situ remediation, you know, can be much more cost-effective than pump and treat. The 10-year discounted capital O&M cost for several sites, we calculated for both, you know, the in-situ technology and pump and treat scenarios, in both of those, the pump and treat were…in the Arkansas site, you know, was generally comparable. The rates that you can expect from a properly designed pump and treat system might be fairly equivalent to the in-situ remedy rates of mass removal, at least initially over that first year. But the operation and maintenance costs of in-situ remedies are much less than those for pump and treat. Overall the in-situ remedies provide huge savings and value over pump and treat systems.
You know, in mass removal, you know, it can be estimated for both pump and treat and in-situ treatment scenarios in those confounding factors where petitioning and low recovery…you know, the petitioning caused by the activated carbon and low product recovery caused by these, you know, different…you know, those beta-elimination pathways that don’t yield like compounds like ethene or at least not as much, you know, you can get over those. So the utilities of doing these aquifer volume, you know, based mass removal estimates is really great. And those constraints are easy to overcome.
So, comparative mass removal assessments have shown that at these subject sites, you know, the mass removal associated with the in-situ remediation is equivalent to or better than that of pump and treat, you know, at least over the periods that we looked at. And I actually expect that the efficiency will continue because pump and treat’s gonna tail off a little bit as they start reaching asymptotic levels, whereas the in-situ has a better ability to penetrate and diffuse into matrices that are a little bit tougher to deliver to initially. And you can get degradation actively happening there as well. So, with that, I think, we might have a little bit of time for questions.
Dane: All right. Thank you very much, Matt. That does conclude the formal section of our presentation. So at this point, we’d like to shift into the Q&A portion of the webcast. Before we do this, just a couple of quick reminders. First, you’ll receive a follow-up email with a brief survey. We really appreciate your feedback so please take a minute to let us know how we did. And also after the webinar, you’ll receive a link to the recording as soon as it’s available. All right. So let’s circle back to the questions. We have a lot of questions. So if we do run out of time before we get to your question, we’ll make an effort to follow up with you after the webinar. All right. So, here’s the first question. It is what about estimating petroleum mass removal?
Matt: Yeah. It’s a good question. Sorry, I didn’t touch on that. But, you know, petroleum and most contaminants, you know, the method of quantifying temporal contaminant mass per saturated soil volume will work. So, you know, go ahead and do it that way. So take a look at the…do that conversion where you take the aqueous samples and the soil samples, mathematically combine them into saturated soil and do the mass assessment with time based upon those. You know, there are also some CO2 and methane mass flux methods out there, but, you know, keeping it simple, mass for saturated soil, you know, works and works well.
Dane: Okay. Thanks, Matt. So next question is can the ISMs be used where the activated carbon is not delivered as a hydrocolloid?
Matt: Yeah. I think this one gets back to like if you don’t have that steric stabilization like the PlumeStop has on it within that. That makes the PlumeStop almost act like a soluble component, not like a colloidal compound, right, that settles out and has distribution issues. Yeah. I think that in native aquifer material, ISMs can also provide some value here, but they might not necessarily be…with these non-hydrocolloid activated carbons, they might not be delivered as efficiently. In order to, I guess it’s not stack the deck, but to make sure that you have a decent assessment of what’s going on in-situ, and you can’t count on the ISM being dosed the same way it would be if it were hydrocolloids that were being applied, you might need to pre-mix in the design dose of the activated carbon into the ISM matrix, that native matrix, you know, then deploy it. You know, then you can pull it with time and see, you know, “Am I getting degradation? Is the mass of sorbed material decreasing?” And it would at least give you a signal that it was time to go out and collect an actual saturated soil sample.
Dane: All right. Okay. Thanks, Matt. So here’s another question. It is both in-situ treatment and pump and treat have been around for a while. Has in-situ always been as efficient with mass removal as pump and treat?
Matt: That’s a great question. So, I think, there’s two components to this. So first of all, recently…over the past 10 years for sure but even more of like over the past 5 years, we’ve learned so much about degradation pathways and that they’re not as simple as kind of what I showed today’s example, that a lot of things go into them and that you need to pay attention to all those inputs to make sure you’ve designed well. So, I think, because those pathways have been…you know, detailed much more significantly recently, it allows design engineers to provide exactly the conditions that are needed to stimulate degradation. But I also think there’s a component…the second part of this is that remedial amendments have improved. Maureen, can you comment on, you know, how remedial amendments have changed over the past, you know, few years, you know, to accommodate this new science?
Maureen: Yeah. Matt. No, I’m happy to. You know, when thinking about, you know, ERD reagents, you can apply that, and you get some removal. But, I think, the advancements particularly with colloidal carbon gives you some more predictability. It also increases longevity. And so, I think, those components make it really important particularly if you’re thinking about a barrier and being able to maintain it over long term. And, I think, then the other aspect is rebound. You know, you may get low levels, or maybe you’re using ERD. It goes down and comes back up again, and you get this rebound, and being able to manage that rebound, that’s something else when you’re working with some of the colloidal carbons. I think that’s really advantageous and something that’s, you know, newer and gives us more tools and better tools for the in-situ.
Dane: Okay. Thanks, Matt and Maureen. So here’s another question. It is regarding the Arkansas site. It says, “You completed two pilot tests. Why did you go with PlumeStop over biogeochemical?”
Matt: Good question. You know, the biogeochemical worked well and so did the PlumeStop, but we saw the biogeochemical as being additive to the PlumeStop. And we actually had a decent background of sulfate and iron, and the missing material what was a fermentable donor, which we were adding to stimulate the biodegradation as well. So, I think, we did get some biogeochemical conditions formed with our application. Good question. They both performed well, but we thought that we could get a biogeochemical component included with the PlumeStop as well.
Dane: Okay. Thanks, Matt. So here’s another question. It is how are bioremediation and iron-based abiotic pathways complementary?
Matt: I know Maureen’s all over this. We were talking about…
Maureen: Yeah. If you want, I’ll jump on this one. You know, Matt actually had touched on some of this, so, I think, a little earlier in his presentation talking about, you know, how you utilize both components. And, I think, they really are complementary, I think, in some aspects. Remember with the iron, that can help you really create those conditions immediately, those reducing conditions, and can have some very fast rates, particularly with the parent compounds. And then the bio just really supports this and may have some better efficiencies maybe even with some of the vinyl and, you know, other daughter products or even some other compounds where ZVI isn’t necessarily, you know, as effective as bio is. So, the two really work well together. And honestly, we’ve internally at Regenesis done a deep dive on some of our in-situ programs, you know, with and without iron, and we certainly have seen a statistically significant, you know, impact on the data that by adding the iron that we’re getting better overall results both in rate and, you know, percent reduction.
Matt: And, I think, that some of, you know, those synergies show up if you take a detailed look at each of the degradation path or each of those, you know, pathways. For example, you know, dehalococcoides, the main actor in sequential degradation of chlorinated solvents, you know, it requires B12. It can’t make B12 itself just like people can’t make B12. We’ve gotta take some vitamins if we wanna get B12 or have, you know, diets that are rich in B12. You know, dehalococcoides is kind of out there on their own because, you know, they don’t have access to these vitamins. But other microbes produce it, and then they’re able to grab access to it. And one of the groups of microbes that can make the B12 are iron reducers. So when you’re adding iron to a system and, you know, Geobacter growing up that makes B12, and it’s probably even the right lower ligand for only, you know, these 4 lower ligands of B12, and DHC uses one of them, so just having, you know, a diverse population of microbes making all sorts of different variants of the B12, you know, things like that, the details of those degradation pathways probably leads to a lot of those synergies that you’re seeing empirically.
Dane: All right. Thank you, Matt and Maureen. So, that is gonna be the end of our webinar today. If we did not get to your question, someone will make an effort to follow up with you. If you’d like more information about engineering solutions from WSP, please visit wsp.com, and if you’d like to learn more about remediation solutions from Regenesis, please visit regenesis.com. Thanks again very much to Matt Burns and Maureen Dooley and thanks to everyone who could join us. Have a great day.